Acadia Pharmaceuticals

(NASDAQ) ACAD

Current Price$23.36

Market Cap$4.00B

Since IPO (2004)+237%

5 Year-11%

1 Year+4%

1 Month+11%

Acadia Pharmaceuticals Financials at a Glance

Market Cap

$4.00B

Revenue (TTM)

$1.10B

Net Income (TTM)

$375.65M

EPS (TTM)

$2.20

P/E Ratio

10.64

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$23.36

Volume

1,495,872

Open

$22.67

Price

$23.36

Volume

1,495,872

Open

$22.67

Previous Close

$23.36

Daily Range

$22.67 - $23.79

52-Week Range

$19.69 - $28.35

Estimated Earnings Date

Aug 5, 2026

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$23.36

Volume

1,495,872

Open

$22.67

Previous Close

$23.36

Daily Range

$22.67 - $23.79

52-Week Range

$19.69 - $28.35

Estimated Earnings Date

Aug 5, 2026

ACAD News

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

Jonathan PoncianoDec 3, 2025

Page 1

ACAD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acadia Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

798

CEO

Catherine Owen Adams

Website

www.acadia.com

Headquarters

San Diego, CA 92130, US

ACAD Financials

Key Financial Metrics (TTM)

Gross Margin

91.47%

Operating Margin

7.39%

Net Income Margin

34.30%

Return on Equity

35.65%

Return on Capital

8.19%

Return on Assets

23.40%

Earnings Yield

9.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.00B

Shares Outstanding

171.24M

Volume

1.50M

Avg. Volume

1.62M

Financials (TTM)

Gross Profit

$1.00B

Operating Income

$80.91M

EBITDA

$126.91M

Operating Cash Flow

$123.49M

Capital Expenditure

$88.94M

Free Cash Flow

$212.43M

Cash & ST Invst.

$851.46M

Total Debt

$50.79M

Acadia Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$268.06M

+9.7%

Gross Profit

$243.27M

+8.6%

Gross Margin

90.75%

N/A

Market Cap

$4.00B

N/A

Market Cap/Employee

$6.13M

N/A

Employees

653

N/A

Net Income

$3.64M

-80.8%

EBITDA

$6.97M

-77.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$851.46M

+24.9%

Total Debt

$50.79M

-9.3%

Accounts Receivable

$148.38M

+30.5%

Inventory

$31.57M

+37.6%

Long Term Debt

$39.00M

-12.6%

Short Term Debt

$11.79M

+3.7%

Return on Assets

23.40%

N/A

Return on Invested Capital

6.22%

N/A

Free Cash Flow

$28.77M

+136.6%

Operating Cash Flow

$33.98M

+67.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$36.18+0.75%

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$37.87+8.79%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$20.33+0.35%

SLNOSoleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.$53.01+0.00%

LGNDLigand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated$284.91+1.96%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$114.97+3.51%

ADMAADMA Biologics, Inc.

ADMAADMA Biologics, Inc.$8.70+0.12%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.44+0.08%

SOFISoFi Technologies

SOFISoFi Technologies$17.31+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

PATHUiPath

PATHUiPath$10.31+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$154.54-0.01%

ONDSOndas

ONDSOndas$7.68-0.10%

Questions About ACAD

What is the current price of Acadia Pharmaceuticals?

Acadia Pharmaceuticals is trading at $23.36 per share.

What is the 52-week range for Acadia Pharmaceuticals?

Over the past 52 weeks, Acadia Pharmaceuticals has traded between $19.69 and $28.35.

How much debt does Acadia Pharmaceuticals have?

As of the most recent reporting period, Acadia Pharmaceuticals reported total debt of $50.79M.

How much cash does Acadia Pharmaceuticals have on hand?

Acadia Pharmaceuticals reported $282.21M in cash and cash equivalents in its most recent financial results.

What is Acadia Pharmaceuticals’s dividend yield?

Acadia Pharmaceuticals does not currently have a dividend yield.

Acadia Pharmaceuticals

Acadia Pharmaceuticals Financials at a Glance

ACAD News

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

Acadia (ACAD) Q2 Revenue Rises 9%

Why Acadia Pharmaceuticals Stock Is Rising Today

2 Growth Stocks I'd Buy on the Dip

2 Supercharged Growth Stocks Billionaires Can't Stop Buying

Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?

Why These 2 Biotech Stocks Made Big Moves Late Thursday

3 Nasdaq Stocks on Watch This Week

ACAD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acadia Pharmaceuticals

ACAD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acadia Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACAD

What is the current price of Acadia Pharmaceuticals?

What is the 52-week range for Acadia Pharmaceuticals?

How much debt does Acadia Pharmaceuticals have?

How much cash does Acadia Pharmaceuticals have on hand?

What is Acadia Pharmaceuticals’s dividend yield?

Premium Investing Services